Schedule 13G ownership disclosure
Ocular Therapeutix Inc
Common Stock, par value $0.0001 per share · CUSIP: 67576A100
Event date: 2024-12-31
- Filing-level shares
- 4,342,500.00
- Percent of class
- 2.76%
- Opaleye Management Inc.
Shares: 4,342,500.00 · Class: 2.76%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-006574
- Form type
- SCHEDULE 13G/A
- Filer
- OCULAR THERAPEUTIX, INC
- CIK
- CIK 1393434
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership